Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 61 AL 75

Anti-amyloid treatment in Alzheimer disease: updated implications for patients with cerebral amyloid angiopathy and other cerebrovascular conditions

Zupan M, Prelog PR, Kramberger MG, Frol S.

Front Neurol. 2026 Aug 19;17:1889769. doi: 10.3389/fneur.2026.1889769. eCollection 2026.

Biochemical modulators of synaptic plasticity: New horizons in Alzheimer's disease treatment

Farzeen I, Nazir MM, Jaan Z, Ghaffar W, Masood A, Yasmeen M, Ashraf A, Różański H.

J Alzheimers Dis. 2026 Sep;113(2):501-518. doi: 10.1177/13872877261469864. Epub 2026 Jul 23.

Modulating the Gut-Microbiota-Brain Axis in Alzheimer's Disease: Therapeutic Potential of Nutritional and Metabolic Factors

Xu B, Li X, Dong S, Zhang Z, Jin D, Li G, Wang J.

CNS Neurosci Ther. 2026 Sep;32(9):e71117. doi: 10.1002/cns.71117.

Neuroinflammatory and molecular pathways in Alzheimer's disease: mechanistic crosstalk and emerging therapeutic opportunities

Thakur A, Sharma R, Kumari S, Prakash D, Devi A.

Inflammopharmacology. 2026 Sep;34(9):6059-6088. doi: 10.1007/s10787-026-02371-7. Epub 2026 Aug 19.

Targeting microglia: A new strategy for the treatment of Alzheimer's disease

Zheng M, Yang M, Su W, Tian L, Gao W.

J Neuroimmunol. 2026 Sep;418:578966. doi: 10.1016/j.jneuroim.2026.578966. Epub 2026 May 14.

Covalent small-molecule RNA targeting in Alzheimer's disease: Computational strategies, challenges and opportunities

Kumar V, Arulsamy S, Sharma S, Kumar S, Kakoty V.

Drug Discov Today. 2026 Sep;31(5):104758. doi: 10.1016/j.drudis.2026.104758. Epub 2026 Aug 4.

Frailty as an underrepresented dimension in clinical trials of Alzheimer's disease therapies

Solfrizzi V, Imbimbo BP.

J Alzheimers Dis. 2026 Sep;113(1):83-88. doi: 10.1177/13872877261466693. Epub 2026 Jul 9.

Characterising patients with Alzheimer's disease in England: a cohort study using data from Clinical Practice Research Datalink linked to Hospital Episode Statistics

Afonso AS, Schroeder KM, Mitchell L, Carragher N, Casey C, Patel N.

BMJ Open. 2026 Aug 28;16(8):e115438. doi: 10.1136/bmjopen-2025-115438.

Comparative risk of amyloid-related imaging abnormalities with anti-amyloid-β monoclonal antibodies: A systematic review and penalized likelihood network meta-analysis of randomized trials

Sharma A, Suresh V, Kola PR, Raj R, Javairia F, Nithyanandam A, Kaur A, Arora H, Uwishema O, Gorty D, Beriwal N, Verma A, Qidwai K, Singh Malhotra H, Kumar Garg R.

J Alzheimers Dis. 2026 Sep;113(1):65-82. doi: 10.1177/13872877261466097. Epub 2026 Jul 11.

Passive Digital Marker-enabled identification and engagement for Alzheimer's disease and related dementias care in primary care: the INCLUDE study protocol

Summanwar D, Lee L, Willis DR, Ben Miled Z, Baucco C, Webber ECC, Perkins AJ, Powell AY, Fowler NR.

BMJ Open. 2026 Sep 8;16(9):e116755. doi: 10.1136/bmjopen-2026-116755.

Adapting the spanish healthcare system for disease-modifying treatments in early-stage alzheimer's disease

Sánchez Valle R, Lleó Bisa A, Villarejo Galende A, Cuartero Rodríguez E, Escudero-Torrella J, Bargallo Alabart N.

J Prev Alzheimers Dis. 2026 Aug;13(7):100586. doi: 10.1016/j.tjpad.2026.100586. Epub 2026 May 5.

Effectiveness of a structured caregiver support program for caregivers of people with Alzheimer's disease: A mixed methods study

Surer HK, Yaylagul NK.

Geriatr Nurs. 2026 Sep;72:104170. doi: 10.1016/j.gerinurse.2026.104170. Epub 2026 Jul 1.

The effect of simultaneous application of plant-rich ketogenic diet and intermittent fasting on early-to-mid-stage Alzheimer's disease: a randomised controlled trial

Tağraf B, Kaygusuz D, Yerlikaya D, Oğul ÖE, Hanoğlu L.

J Nutr Health Aging. 2026 Sep;30(9):100930. doi: 10.1016/j.jnha.2026.100930. Epub 2026 Jul 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias